A citation-based method for searching scientific literature

Anne S Reiner, Esther M John, Jennifer D Brooks, Charles F Lynch, Leslie Bernstein, Lene Mellemkjær, Kathleen E Malone, Julia A Knight, Marinela Capanu, Sharon N Teraoka, Patrick Concannon, Xiaolin Liang, Jane C Figueiredo, Susan A Smith, Marilyn Stovall, Malcolm C Pike, Robert W Haile, Duncan C Thomas, Colin B Begg, Jonine L Bernstein. J Clin Oncol 2013
Times Cited: 77

List of co-cited articles
458 articles co-cited >1

Times Cited
  Times     Co-cited

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Hazel B Nichols, Amy Berrington de González, James V Lacey, Philip S Rosenberg, William F Anderson. J Clin Oncol 2011

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007

Perceptions of contralateral breast cancer: an overestimation of risk.
Andrea Abbott, Natasha Rueth, Susan Pappas-Varco, Karen Kuntz, Elizabeth Kerr, Todd Tuttle. Ann Surg Oncol 2011

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009

Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
Tari A King, Rita Sakr, Sujata Patil, Inga Gurevich, Michelle Stempel, Michelle Sampson, Monica Morrow. J Clin Oncol 2011

Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Katharine Yao, Andrew K Stewart, David J Winchester, David P Winchester. Ann Surg Oncol 2010

Prophylactic mastectomy for the prevention of breast cancer.
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004

Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
Judy C Boughey, Tanya L Hoskin, Amy C Degnim, Thomas A Sellers, Joanne L Johnson, Melanie J Kasner, Lynn C Hartmann, Marlene H Frost. Ann Surg Oncol 2010

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Todd M Tuttle, Stephanie Jarosek, Elizabeth B Habermann, Amanda Arrington, Anasooya Abraham, Todd J Morris, Beth A Virnig. J Clin Oncol 2009

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Marion Kiechle, Nina Ditsch, Wolfgang Janni, Christoph Mundhenke, Michael Golatta,[...]. Breast Cancer Res 2012

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009

Epidemiology of contralateral breast cancer.
Y Chen, W Thompson, R Semenciw, Y Mao. Cancer Epidemiol Biomarkers Prev 1999

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011

Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Allison W Kurian, Daphne Y Lichtensztajn, Theresa H M Keegan, David O Nelson, Christina A Clarke, Scarlett L Gomez. JAMA 2014

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
Jack Cuzick, Ivana Sestak, Michael Baum, Aman Buzdar, Anthony Howell, Mitch Dowsett, John F Forbes. Lancet Oncol 2010

Second primary breast cancer occurrence according to hormone receptor status.
Allison W Kurian, Laura A McClure, Esther M John, Pamela L Horn-Ross, James M Ford, Christina A Clarke. J Natl Cancer Inst 2009

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010

Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Abenaa M Brewster, Isabelle Bedrosian, Patricia A Parker, Wenli Dong, Susan K Peterson, Scott B Cantor, Melissa Crosby, Yu Shen. Cancer 2012

Review of risk factors for the development of contralateral breast cancer.
Ingrid M Lizarraga, Sonia L Sugg, Ronald J Weigel, Carol E H Scott-Conner. Am J Surg 2013

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Babette Siebold Saltzman, Kathleen E Malone, Jean A McDougall, Janet R Daling, Christopher I Li. Breast Cancer Res Treat 2012

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
Bernard Fisher, Stewart Anderson, John Bryant, Richard G Margolese, Melvin Deutsch, Edwin R Fisher, Jong-Hyeon Jeong, Norman Wolmark. N Engl J Med 2002

Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
E A Peralta, J D Ellenhorn, L D Wagman, A Dagis, J S Andersen, D Z Chu. Am J Surg 2000

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014

Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
Marlene H Frost, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan,[...]. J Clin Oncol 2005

Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
U Güth, M E Myrick, C T Viehl, W P Weber, A M Lardi, S M Schmid. Eur J Surg Oncol 2012

Issues of regret in women with contralateral prophylactic mastectomies.
L L Montgomery, K N Tran, M C Heelan, K J Van Zee, M J Massie, D K Payne, P I Borgen. Ann Surg Oncol 1999

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Michael Schaapveld, Otto Visser, W J Louwman, Pax H B Willemse, Elisabeth G E de Vries, Winette T A van der Graaf, Renée Otter, Jan Willem W Coebergh, Flora E van Leeuwen. Breast Cancer Res Treat 2008

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver,[...]. Breast Cancer Res 2004

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Kelly-Anne Phillips, Roger L Milne, Matti A Rookus, Mary B Daly, Antonis C Antoniou, Susan Peock, Debra Frost, Douglas F Easton, Steve Ellis, Michael L Friedlander,[...]. J Clin Oncol 2013

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.
Lisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, Lene Mellemkjaer, Robert W Haile, Charles F Lynch, Kathleen E Malone, Hoda Anton-Culver, Jane Christensen, Bryan Langholz,[...]. J Natl Cancer Inst 2008

Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
Catherine E Pesce, Erik Liederbach, Tomasz Czechura, David J Winchester, Katharine Yao. J Am Coll Surg 2014

Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.
Megan E Miller, Tomasz Czechura, Brigid Martz, Mary E Hall, Catherine Pesce, Nora Jaskowiak, David J Winchester, Katharine Yao. Ann Surg Oncol 2013

Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Pamela R Portschy, Karen M Kuntz, Todd M Tuttle. J Natl Cancer Inst 2014

Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.
Oluwadamilola Motunaryo Fayanju, Carolyn R T Stoll, Susan Fowler, Graham A Colditz, Julie A Margenthaler. Ann Surg 2014

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.